Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Inflammation Clinical Trials

15 recruiting trials for Inflammation. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
15
Total Trials
15
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06272461

Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery

Patients undergoing open colorectal surgery were randomly divided into two groups: Intravenous Lidocaine (IV-Lido) vs Intravenous Ketamine (IV-Keta). For the IV-Lido group,...

Sponsor: University Tunis El ManarEnrolling: 501 location
RECRUITINGNCT06055322

Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD

This project aims to adapt, implement, and evaluate a Dialectical Behavior Therapy skills training group intervention for aging adult family caregivers of person with Alzheimer's...

Sponsor: Texas Tech UniversityEnrolling: 1001 location
RECRUITINGNCT05961865

Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation

It is a non-pharmacological (biological), spontaneous observational study. The main objective is to evaluate the correlation between inflammation markers and local adiposity,...

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoEnrolling: 1801 location
RECRUITINGPhase 2NCT06927739

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated...

Sponsor: AbcentraEnrolling: 24020 locations
RECRUITINGNCT03125655

Regulation of Inflammatory Genes in Psoriasis

Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated...

Sponsor: University of Alabama at BirminghamEnrolling: 131 location
RECRUITINGNCT06390189

Inflammatory Resolution in Cardiometabolic Health and Disease

The specific aim of this study is to determine molecular pathways that differentiate metabolically healthy vs unhealthy human phenotypes, and to investigate the therapeutic...

Sponsor: University of AarhusEnrolling: 2401 location
RECRUITINGNCT04485871

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Every 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk...

Sponsor: Institut de Recherches Cliniques de MontrealEnrolling: 481 location
RECRUITINGNCT07343336

Landscape of Gout in French Polynesia.

The aim of this research is to characterise the genetic and molecular landscape of gout, inflammation and metabolic diseases, as well as the associated molecular, anthropomorphic...

Sponsor: Lille Catholic UniversityEnrolling: 27506 locations
RECRUITINGNCT06389539

Synbiotic to Attenuate Resorption of the Skeleton

This randomized, double blind, placebo controlled clinical trial will test the efficacy of a probiotic/prebiotic combination ("synbiotic") on the skeleton in older women.

Sponsor: Hebrew SeniorLifeEnrolling: 2201 location
RECRUITINGNCT06840717

Association Between Genetic Polymorphisms and Type 2 Asthma in Children

To further understand the role of gene single nucleotide polymorphism (SNP) in the occurrence of type 2 inflammation-related asthma in children by analyzing the gene single...

Sponsor: Guangzhou Institute of Respiratory DiseaseEnrolling: 3001 location
RECRUITINGNCT07011394

Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational...

Asthma is a common inflammatory respiratory disease affecting 11% of Canadians, but its diagnosis remains challenging, leading to delays in treatment or overtreatment. Spirometry...

Sponsor: Université de SherbrookeEnrolling: 1233 locations
RECRUITINGNCT06853340

Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock

In septic shock, bacterial LPS is able to activate the CaSR of cardiomyocytes inducing their apoptosis in vitro. CaSR activation in monocytes is responsible for activation of the...

Sponsor: Centre Hospitalier Universitaire, AmiensEnrolling: 661 location
RECRUITINGNCT06473844

Efficacy of SGLT2 Inhibitors in Adults With Sepsis

Goal of this clinical trial is to examine the safety and efficacy of SGLT2 inhibitors on the clinical outcomes in patients with sepsis. Main study outcomes are as follows: (i)...

Sponsor: Hospital Authority, Hong KongEnrolling: 603 locations
RECRUITINGNCT02437396

Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease

The objective of this study is to evaluate oxidative stress and/or inflammation in patients with Gaucher disease type I using a series of biomarkers and correlate with...

Sponsor: University of MinnesotaEnrolling: 341 location
RECRUITINGPhase 1NCT06161415

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study

The LION Study is a prospective, single-center phase 1 clinical trial to evaluate the safety, tolerability, and distribution of Laquinimod administered as topical eye drops for...

Sponsor: Quan Dong NguyenEnrolling: 121 location

Frequently Asked Questions

There are currently 15 clinical trials for Inflammation, with 15 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Inflammation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Inflammation, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.

this entity is one of the data points covered by this site’s U.S. clinical trials and research registries dataset. The detail above comes directly from the NIH ClinicalTrials.gov registry; the context that follows situates the headline numbers against the broader distribution across active and historical clinical trials.

The methodology behind every numeric value on this page is publicly documented on the the NIH ClinicalTrials.gov registry portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within active and historical clinical trials with similar size, similar exposure, or similar geography — not the national-level summary alone.